Cormedix Inc (CRMD) financials
Cormedix revenue and earnings by year
Cormedix's revenue was $312 million in the fiscal year to December 31, 2025, up 617.0% from the year before. Net income was $163 million, 52.3% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 123.5% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 9 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 312 | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue growth | 617.0% | 66362.8% | -65.7% | -20.2% | -15.5% | -34.1% | 30.5% | 47.0% | — |
| Gross profit | 276 | 40 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
| Gross margin | 88.5% | 92.7% | 94.3% | 22.0% | 14.4% | -31.8% | 7.7% | 65.1% | -63.6% |
| Operating income | 150 | -22 | -31 | -29 | -27 | -21 | -27 | -33 | -25 |
| Operating margin | 48.2% | -51.4% | -46819.9% | -15417.5% | -11378.4% | -7416.3% | -6250.4% | -9997.4% | -11048.8% |
| Net income | 163 | -18 | -30 | -28 | -22 | -16 | -27 | -33 | -25 |
| Net margin | 52.3% | -41.2% | -45409.9% | -14774.7% | -9207.7% | -5801.3% | -6242.4% | -10023.4% | -10996.5% |
| Diluted EPS | $2.04 | -$0.30 | -$0.74 | -$0.75 | -$0.76 | -$1.78 | -$1.52 | -$3.10 | -$3.15 |
| Free cash flow | 173 | -51 | -25 | -23 | -22 | -15 | -24 | -29 | -22 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CRMD in Markets.
How Cormedix makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Defen Cath | $66.1M | 64.9% |
| Melinta Portfolio | $28.2M | 27.7% |
| Contract Revenue | $4.97M | 4.9% |
| Grant Income | $2.62M | 2.6% |
See also: CRMD valuation and P/E history · CRMD returns
No forecast, no recommendation. This page describes Cormedix Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.